← Leaderboards
David Esteban Sanin Pena
Johns Hopkins University
$205,736
Attributed
$411,472
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $229.7K · FY2023–24$250K$187.5K$125K$62.5K$0
'23
'24
Funding mix
By agency
NIH$411,472 · 1
By mechanism
R21$411,472 · 1
Top collaborators
- Samuel R Denmeade2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Samuel R Denmeade$5,431,317
- Elizabeth Marion Jaffee$29,780,612
- Kenneth J. Pienta$43,861,680
- Shawn Lupold$4,097,268
- Dan E Berkowitz$6,149,594
Others in their field
Other Rising Stars on “Conceptions”
- Alaina J Harkness · Current Innovation, Nfp$13,724,091
- Meera Sampath · Suny At Binghamton$9,956,488
- Hong-Ngoc B. Nguyen · University Of Minnesota$6,812,121
- George Gaitanaris · Omeros Corporation$6,689,019
- Christine W Hockett · Avera Mckennan$6,292,079
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
Research focus
ConceptionsAdvanced DiseaseAdvanced Prostate CancerAndrogen Deprivation TherapyAffectAndrogen ReceptorAftercareAndrogen TherapyAnimal ModelAnti-Tumor Immune ResponseArginaseBiochemicalBiopsyCancer PatientCastrationAndrogensCell PhysiologyCellsCellular BiologyCessation Of LifeClinical TrialsCohortComputational BiologyCoupling
Grant awards (2)
The Role of Myeloid-Derived Suppressor Cells in Resistance to Bipolar Androgen Therapy in Patients with Advanced Prostate Cancer$181,813
R21 · FY2024 · CA · contact PI
The Role of Myeloid-Derived Suppressor Cells in Resistance to Bipolar Androgen Therapy in Patients with Advanced Prostate Cancer$229,659
R21 · FY2023 · CA · contact PI